NYSE · Medical Care Facilities · USD
Chemed Corporation (CHE) Stock Analysis
Chemed Corporation (CHE) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CHE Key Statistics
As of Sep 4, 2026Trading
- Open
- $519.62
- Previous Close
- $524.45
- Day's Range
- 519.23–525.63
- 52-Week Range
- 365.21–557.00
- Volume
- 84.30K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.51
Valuation
- Market Cap
- $6.79B
- P/E Ratio
- 26.39
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 18.89
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.91
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.62
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 19.70
Financials (FY)
- Revenue (FY)
- $2.53B+4.06%
- Net Income (FY)
- $265.24M−12.17%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 10.60%
- Shares Outstanding
- 13.07M
- 1-Year Return
- +13.54%
Dividend and dates
- Dividend
- $2.80+0.53%
- Ex-Dividend Date
- August 17, 2026
- Earnings Date
- October 27, 2026
- Avg Volume
- 181.26K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
CHE Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +21.82% |
| 2025 | −18.87% |
| 2024 | −9.11% |
| 2023 | +14.90% |
| 2022 | −3.22% |
| 2021 | −0.38% |
| 2020 | +21.59% |
| 2019 | +55.58% |
| 2018 | +17.01% |
| 2017 | +52.32% |
| 2016 (partial year) | +11.91% |
As of September 4, 2026.
CHE Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $2.53B | $265.24M | 10.5% |
| 2024 | $2.43B | $302.00M | 12.4% |
| 2023 | $2.26B | $272.51M | 12.0% |
| 2022 | $2.13B | $249.62M | 11.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $2.53B | $823.18M | $341.16M | $265.24M | 10.5% |
| 2024 | $2.43B | $854.35M | $366.94M | $302.00M | 12.4% |
| 2023 | $2.26B | $798.82M | $342.83M | $272.51M | 12.0% |
| 2022 | $2.13B | $765.09M | $347.19M | $249.62M | 11.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CHE Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.90 | 3 | — |
| 2025 | $2.20 | 4 | +22.2% |
| 2024 | $1.80 | 4 | +15.4% |
| 2023 | $1.56 | 4 | +5.4% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.90 | 3 | — |
| 2025 | $2.20 | 4 | +22.2% |
| 2024 | $1.80 | 4 | +15.4% |
| 2023 | $1.56 | 4 | +5.4% |
| 2022 | $1.48 | 4 | +5.7% |
| 2021 | $1.40 | 4 | +6.1% |
| 2020 | $1.32 | 4 | +6.5% |
| 2019 | $1.24 | 4 | +6.9% |
| 2018 | $1.16 | 4 | +7.4% |
| 2017 | $1.08 | 4 | +315.4% |
| 2016 | $0.26 | 1 | — |
Most recent payment: $0.63 per share, ex-dividend August 17, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
CHE Valuation vs Medical Care Facilities Median
Median of 57 stocks| Metric | CHE | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 26.39 | 19.84 | 33% above |
| P/S ratio | 2.62 | 0.95 | 175% above |
| Profit margin | 10.60% | 3.06% | 7.5 pts above |
Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
YahooThe Capitol Forum Posts On X "Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and 'Fudged' Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation"
BenzingaOPCH or CHE: Which Is the Better Value Stock Right Now?
YahooChemed Corporation Declares Quarterly Dividend of 70 Cents
YahooAVAH vs. CHE: Which Stock Should Value Investors Buy Now?
YahooChemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value
SeekingAlpha
All 20 articles ↓Show fewer ↑
Chemed (CHE) Price Target Increased by 23.63% to 563.04
FintelOppenheimer Maintains Outperform on Chemed, Raises Price Target to $590
BenzingaChemed (CHE) Deepens Buybacks as Activist Pressure Mounts – What Does This Say About Strategy?
YahooCHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
YahooRBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $548
BenzingaChemed Corp (CHE) Q2 2026 Earnings Call Highlights: Strong Vitas Performance and Strategic ...
YahooChemed Q2 Earnings Call Highlights
YahooChemed Corporation (CHE) Q2 2026 Earnings Call Transcript
SeekingAlphaChemed Corporation Q2 2026 Earnings Call Summary
YahooChemed Corporation 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaChemed (CHE) Tops Q2 Earnings and Revenue Estimates
YahooChemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations
YahooChemed Corp (NYSE:CHE) High Growth Stock Surges on Earnings Beat and Raised Guidance
ChartMillChemed Reports Second-Quarter 2026 Results
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$87.68B
THCTenet Healthcare Corporation
$21.34B
FMSFresenius Medical Care AG
$12.06B
EHCEncompass Health Corporation
$12.01B
DVADaVita Inc.
$11.74B
UHSUniversal Health Services, Inc.
$10.00B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B













